Sur C, Quirk K, Dewar D, Atack J, McKernan R
Department of Biochemistry, Merck Sharp and Dohme Research Laboratories, Harlow, Essex, CM20 2QR, UK.
Mol Pharmacol. 1998 Nov;54(5):928-33. doi: 10.1124/mol.54.5.928.
The gamma-aminobutyric acid (GABA)A receptor is a hetero-oligomer consisting of five subunits, the combination of which confers unique pharmacological properties to the receptor. To understand the physiological role of native GABAA receptors, it is critical to determine their subunit compositions. The pharmacological characteristics of human alpha5 beta3 gamma2 and alpha5beta3gamma3 GABAA receptors stably expressed in L(tk-) cells were characterized with the alpha5-selective ligand [3H]L-655,708 and compared with the pharmacological characteristics of [3H]L-655,708 binding sites from rat and human hippocampus. Saturation analyses revealed a 9-fold selective affinity of [3H]L-655,708 for alpha5 beta3 gamma2 receptors (Kd = 1.7 +/- 0.4 nM), compared with alpha5 beta3 gamma3 receptors (Kd = 15 +/- 3 nM). Rat and human hippocampal [3H]L-655,708 binding sites had affinities of 2.2 +/- 0.6 and 1.0 +/- 0.2 nM, respectively, comparable to the affinity of alpha5 beta3 gamma2 receptors. Pharmacological analysis of [3H]L-655,708 binding sites in rat and human hippocampi revealed a strong correlation with the affinities of seven benzodiazepine site ligands for alpha5 beta3 gamma2 but not alpha5 beta3 gamma3 receptors. Immunoprecipitation of [3H]L-655,708 binding sites from rat hippocampus with a gamma2-selective antibody yielded 19 +/- 4% of total benzodiazepine binding sites measured using [3H]Ro15-1788, whereas no specific binding was measured after immunoprecipitation with an anti-gamma3 antibody. Combinatorial immunoprecipitations of [3H]muscimol binding sites with anti-alpha5 and anti-gamma2 or anti-alpha5 and anti-gamma3 antibodies established the preferential expression of alpha5 gamma2 receptors, accounting for 22 +/- 2% of total rat hippocampal GABAA receptors. These observations provide pharmacological and structural evidence for the prevalence of alpha5 beta3 gamma2 GABAA receptors in rat hippocampus, despite the clustering of alpha5 and gamma3 loci on the same chromosome.
γ-氨基丁酸(GABA)A受体是一种由五个亚基组成的异源寡聚体,这些亚基的组合赋予了该受体独特的药理学特性。为了了解天然GABAA受体的生理作用,确定其亚基组成至关重要。用α5选择性配体[3H]L-655,708对稳定表达于L(tk-)细胞中的人α5β3γ2和α5β3γ3 GABAA受体的药理学特性进行了表征,并与大鼠和人海马体中[3H]L-655,708结合位点的药理学特性进行了比较。饱和分析显示,[3H]L-655,708对α5β3γ2受体(Kd = 1.7±0.4 nM)的选择性亲和力是α5β3γ3受体(Kd = 15±3 nM)的9倍。大鼠和人海马体中[3H]L-655,708结合位点的亲和力分别为2.2±0.6 nM和1.0±0.2 nM,与α5β3γ2受体的亲和力相当。对大鼠和人海马体中[3H]L-655,708结合位点的药理学分析表明,其与七种苯二氮䓬位点配体对α5β3γ2受体而非α5β3γ3受体的亲和力密切相关。用γ2选择性抗体对大鼠海马体中[3H]L-655,708结合位点进行免疫沉淀,得到的苯二氮䓬结合位点占使用[3H]Ro15-1788测量的总结合位点的19±4%,而用抗γ3抗体免疫沉淀后未检测到特异性结合。用抗α5和抗γ2或抗α5和抗γ3抗体对[3H]蝇蕈醇结合位点进行联合免疫沉淀,确定了α5γ2受体的优先表达,占大鼠海马体中总GABAA受体的22±2%。这些观察结果为α5β3γ2 GABAA受体在大鼠海马体中的普遍存在提供了药理学和结构证据,尽管α5和γ3基因座在同一条染色体上聚集。